Pulmonx News

Pulmonx Analyst Ratings

BenzingaMay 2 15:15 ET

Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $15

BenzingaMay 2 15:16 ET

Pulmonx Analyst Ratings

BenzingaApr 3 12:04 ET

Piper Sandler Remains a Buy on Pulmonx (LUNG)

TipRanksApr 3 07:06 ET

Analyst Ratings For Pulmonx

BenzingaFeb 23 07:00 ET

Pulmonx Analyst Ratings

BenzingaFeb 22 11:17 ET

Buy Rating for Pulmonx: Strategic Growth and Global Expansion Underpin Optimism

TipRanksJan 9 07:16 ET

Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $12

BenzingaOct 31, 2023 14:18 ET

Pulmonx Analyst Ratings

BenzingaOct 31, 2023 14:17 ET

Pulmonx (LUNG) Receives a Buy From Craig-Hallum

TipRanksOct 31, 2023 09:16 ET

Piper Sandler Sticks to Their Buy Rating for Pulmonx (LUNG)

TipRanksOct 31, 2023 06:36 ET

Analysts Conflicted on These Healthcare Names: Revvity (RVTY), Pulmonx (LUNG) and Roche Holding AG (OtherRHHVF)

TipRanksOct 31, 2023 05:10 ET

Analysts Are Bullish on Top Healthcare Stocks: Pulmonx (LUNG), Ligand Pharma (LGND)

TipRanksOct 11, 2023 09:03 ET

Analysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Pulmonx (LUNG) and Orchestra BioMed Holdings (OBIO)

TipRanksOct 11, 2023 07:02 ET

Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Arcus Biosciences (RCUS) and 89bio (ETNB)

TipRanksOct 10, 2023 21:01 ET

Craig-Hallum Initiates Coverage On Pulmonx With Buy Rating, Announces Price Target of $18

BenzingaSep 5, 2023 08:51 ET

Pulmonx Analyst Ratings

BenzingaSep 5, 2023 08:50 ET

Analysts' Top Healthcare Picks: Pulmonx (LUNG), Omnicell (OMCL)

TipRanksSep 5, 2023 08:30 ET

Piper Sandler Maintains Overweight on Pulmonx, Raises Price Target to $17

BenzingaAug 3, 2023 12:41 ET

Pulmonx Analyst Ratings

BenzingaAug 3, 2023 12:40 ET